If you are still experiencing significant nausea, vomiting, or diarrhea at the end of a 4-week dose block, stay at the current dose for another 2-4 weeks before attempting the next increase
The following table is cross-trial (drawn from separate studies with different populations, durations, and dose designs, not a head-to-head trial) so direct ranking requires caution: For full side-by-side comparisons see Retatrutide vs Tirzepatide and Retatrutide vs Semaglutide
Curry is a board-certified general surgeon and bariatric surgeon who serves as Medical Director of JourneyLite Physicians and JourneyLite Surgery Center in Cincinnati, Ohio
"Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci
Some patients experience transient visual disturbances, particularly when starting semaglutide or adjusting dosages
Hashimoto's thyroiditis is an autoimmune condition where your immune system produces antibodies, specifically thyroid peroxidase antibodies (TPO) and thyroglobulin antibodies (TgAb), that attack your thyroid tissue